BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21332943)

  • 21. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.
    Kannagi M; Shida H; Igarashi H; Kuruma K; Murai H; Aono Y; Maruyama I; Osame M; Hattori T; Inoko H
    J Virol; 1992 May; 66(5):2928-33. PubMed ID: 1373197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New treatment strategy for adult T-cell leukemia targeting for anti-tumor immunity and a longevity gene-encoded protein].
    Kozako T
    Yakugaku Zasshi; 2011; 131(7):1061-72. PubMed ID: 21720136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
    Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.
    Koenig S; Woods RM; Brewah YA; Newell AJ; Jones GM; Boone E; Adelsberger JW; Baseler MW; Robinson SM; Jacobson S
    J Immunol; 1993 Oct; 151(7):3874-83. PubMed ID: 7690819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult T-cell leukemia: future prophylaxis and immunotherapy.
    Kannagi M; Harashima N; Kurihara K; Utsunomiya A; Tanosaki R; Masuda M
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):369-76. PubMed ID: 15161436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax-specific CTL response in adult T-cell leukemia patients.
    Ishizawa M; Ganbaatar U; Hasegawa A; Takatsuka N; Kondo N; Yoneda T; Katagiri K; Masuda T; Utsunomiya A; Kannagi M
    Cancer Sci; 2021 Mar; 112(3):1161-1172. PubMed ID: 33410215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tax unleashed: fulminant Tax-positive Adult T-cell Leukemia/Lymphoma after failed allogeneic stem cell transplantation.
    Ghez D; Renand A; Lepelletier Y; Sibon D; Suarez F; Rubio MT; Delarue R; Buzyn A; Beljord K; Tanaka Y; Varet B; Hermine O
    J Clin Virol; 2009 Dec; 46(4):378-80. PubMed ID: 19836302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
    J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune recognition of human T-cell leukemia virus type-I (HTLV-I) by MHC-restricted cytotoxic T lymphocytes.
    Tanaka Y
    Kitasato Arch Exp Med; 1992 Sep; 65(2-3):79-85. PubMed ID: 1308259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
    Jacobson S; Reuben JS; Streilein RD; Palker TJ
    J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation.
    Nagasaki M; Zhang J; Morikawa S; Harada T; Nabika T; Tanaka Y
    Pathol Int; 2005 May; 55(5):264-72. PubMed ID: 15871724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide-HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections.
    Tomaru U; Yamano Y; Nagai M; Maric D; Kaumaya PT; Biddison W; Jacobson S
    Nat Med; 2003 Apr; 9(4):469-76. PubMed ID: 12652294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is human T-cell lymphotropic virus type I really silent?
    Asquith B; Hanon E; Taylor GP; Bangham CR
    Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1013-9. PubMed ID: 11186302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective efficacy of multiepitope human leukocyte antigen-A*0201 restricted cytotoxic T-lymphocyte peptide construct against challenge with human T-cell lymphotropic virus type 1 Tax recombinant vaccinia virus.
    Sundaram R; Lynch MP; Rawale S; Dakappagari N; Young D; Walker CM; Lemonnier F; Jacobson S; Kaumaya PT
    J Acquir Immune Defic Syndr; 2004 Nov; 37(3):1329-39. PubMed ID: 15483462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.
    Yashiki S; Fujiyoshi T; Arima N; Osame M; Yoshinaga M; Nagata Y; Tara M; Nomura K; Utsunomiya A; Hanada S; Tajima K; Sonoda S
    AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1047-61. PubMed ID: 11485622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.